iifl-logo

Aarti Drugs Ltd Share Price Live

₹409.95
(-0.05%)
Dec 3, 2025|02:59:55 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Equities

Futures

Option

  • Open₹409.9
  • Day's High₹413.25
  • 52 Wk High₹564.05
  • Prev. Close₹410.15
  • Day's Low₹405.6
  • 52 Wk Low ₹312
  • Turnover (lac)479.37
  • P/E19.66
  • Face Value₹10
  • Book Value₹147.01
  • EPS20.86
  • Mkt. Cap (Cr.)₹3,741.61
  • Div. Yield0.24
View All Historical Data

No Record Found

Loading...

Aarti Drugs Ltd KEY RATIOS

Sector

Pharmaceuticals

Open

₹409.9

Prev. Close

₹410.15

Turnover(Lac.)

₹479.37

Day's High

₹413.25

Day's Low

₹405.6

52 Week's High

₹564.05

52 Week's Low

₹312

Book Value

₹147.01

Face Value

₹10

Mkt Cap (₹ Cr.)

3,741.61

P/E

19.66

EPS

20.86

Divi. Yield

0.24

Aarti Drugs Ltd Corporate Action

29 Jan 2025

12:00 AM

Dividend

Dividend Amount: 1

Record Date: 04 Feb, 2025

arrow

1 Sep 2025

12:00 AM

AGM

Announcement Date: 01 Sep, 2025

arrow

31 Oct 2025

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

Aarti Drugs Ltd NEWS AND UPDATE

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center

Demat Account

View More

Trading Account

View More

Aarti Drugs Ltd SHAREHOLDING SNAPSHOT

16 Dec, 2025|04:38 AM
Sep-2025Jun-2025Mar-2025Dec-2024
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 54.72%

Foreign: 0.00%

Indian: 54.72%

Non-Promoter- 12.58%

Institutions: 12.58%

Non-Institutions: 32.69%

Custodian: 0.00%

Read More
Share PriceShare Price

Aarti Drugs Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Y/e 31 Mar( In .Cr)Mar-2025Mar-2024Mar-2023Mar-2022

Equity Capital

91.27

91.94

92.6

92.6

Preference Capital

0

0

0

0

Reserves

1,160.08

1,083.27

1,021.7

879.57

Net Worth

1,251.35

1,175.21

1,114.3

972.17

Minority Interest

View Balance Sheet
Y/e 31 Mar( In .Cr)Mar-2022Mar-2021Mar-2020Mar-2018

Revenue

2,251.17

1,914.89

1,634.92

1,140.45

yoy growth (%)

17.56

17.12

43.35

4.75

Raw materials

-1,480.52

-1,139.91

-1,045.87

-700.52

As % of sales

65.76

59.52

63.97

61.42

Employee costs

-69.31

-69.28

-60.09

-50.48

View Profit & Loss
Y/e 31 Mar( In .Cr)Mar-2022Mar-2021Mar-2020Mar-2018

Profit before tax

255.49

337.48

166.59

112.21

Depreciation

-47.39

-47.59

-46.66

-37.79

Tax paid

-60.5

-80

-39.3

-38.8

Working capital

194.84

155.99

28.06

98.02

Other operating items

View Cash Flow
Y/e 31 MarMar-2022Mar-2021Mar-2020Mar-2018

Growth matrix (%)

Revenue growth

17.56

17.12

43.35

4.75

Op profit growth

-20.7

64.17

34.4

3.66

EBIT growth

-23.47

81.13

36.89

2.07

Net profit growth

-24.33

89.94

84.81

-2.73

View Ratios
Particulars (Rupees in Crores.)Mar-2025Mar-2024Mar-2023Mar-2022Mar-2021

Gross Sales

2,387.03

2,528.58

2,716.05

2,488.65

2,154.78

Excise Duty

0

0

0

0

0

Net Sales

2,387.03

2,528.58

2,716.05

2,488.65

2,154.78

Other Operating Income

0

0

0

0

0

Other Income

16.36

4.03

2.19

11.32

4.74

Aarti Drugs Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Sun Pharmaceutical Industries Ltd

SUNPHARMA

1,799.5

92.34,31,412.42564.220.894,511.2799.24

Divis Laboratories Ltd

DIVISLAB

6,417.5

67.761,70,343.226960.472,660578.26

Torrent Pharmaceuticals Ltd

TORNTPHARM

3,728

59.131,26,185.415970.162,707249.83

Cipla Ltd

CIPLA

1,516.6

23.571,22,510.621,210.531.054,495.16411.56

Dr Reddys Laboratories Ltd

DRREDDY

1,275.2

19.731,06,522.7387.30.634,602.9377.56

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

View All Peer Comparision

MORE ABOUT Aarti Drugs Ltd

Management

Register Office

Registrar Office

CMD & Executive Director

Prakash M Patil

ED / MD / Promoter

Rashesh C Gogri

ED / Joint MD / Promoter

Harshit M Savla

E D & Wholetime Director

Harit P Shah

WTD & Executive Director

Uday M Patil

Non Executive Director

Narendra Jagannath Salvi

Independent Non Exe. Director

Ankit Vikram Paleja

Independent Non Exe. Director

Bhaskar Narayan Thorat

Independent Non Exe. Director

Neha Gada

Independent Non Exe. Director

Hasmukh Dedhia

Independent Non Exe. Director

Sandeep Madhusudan Joshi

Independent Non Exe. Director

Shri Ajit E. Venugopalan

Company Sec. & Compli. Officer

Rushikesh V Deole

Chairman Emeritus

Chandrakant V. Gogri

Registered Office

Plot No N-198 MIDC Tarapur,

Pamtembhi Village Palghar Tal,

Maharashtra - 401506

Tel: 91-22-24072249

Website: http://www.aartidrugs.com

Email: investorrelations@aartidrugs.com

Registrar Office

C-101 247 Park,

L B S Marg, Vikhroli West,

Mumbai-400083

Tel: 91-22-49186000

Website: www.linkintime.co.in

Email: paytm.ipo@linkintime.co.in

Summary

Aarti Drugs Limited (ADL), incorporated in September, 1984 is a prominent manufacturer of APIs, Pharma Intermediates, and Specialty Chemicals. The Company operates as part of the Aarti Group, a conglo...
Read More

Reports by Aarti Drugs Ltd

Company FAQs

What is the Aarti Drugs Ltd share price today?

The Aarti Drugs Ltd shares price on NATIONAL STOCK EXCHANGE (NSE) is ₹409.95 today.

What is the Market Cap of Aarti Drugs Ltd?

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Aarti Drugs Ltd is ₹3741.61 Cr. as of 03 Dec ‘25

What is the PE and PB ratio of Aarti Drugs Ltd?

The PE and PB ratios of Aarti Drugs Ltd is 19.66 and 2.79 as of 03 Dec ‘25

What is the 52 Week High and Low of Aarti Drugs Ltd?

The 52-week high/low is the highest and lowest price at which a Aarti Drugs Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Aarti Drugs Ltd is ₹312 and ₹564.05 as of 03 Dec ‘25

What is the CAGR of Aarti Drugs Ltd?

Aarti Drugs Ltd's CAGR for 5 Years at -9.99%, 3 Years at -2.48%, 1 Year at -8.92%, 6 Month at -11.18%, 3 Month at -12.03% and 1 Month at -17.27%.

What is the shareholding pattern of Aarti Drugs Ltd?

The shareholding pattern of Aarti Drugs Ltd is as follows:
Promoters - 54.72 %
Institutions - 12.59 %
Public - 32.69 %

QUICKLINKS FOR Aarti Drugs Ltd

Information
Share PriceFutures PriceOption ChainHistorical Data
Financials
Profit & LossBalance SheetCash FlowKey Ratios
Results
Quarterly ResultHalf Yearly ResultNine Monthly ResultAnnual Result
News
Company
testing
  • testing
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

testing
  • testing
  • testing

ATTENTION INVESTOR

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor), PFRDA Reg. No. PoP 20092018

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.